FDA’s Win-Win: More Comprehensive IND Safety Reports With Minimal Effort Due To Harmonization
Executive Summary
New proposed rule calls for replacing US FDA’s current annual reporting requirements for INDs with a safety update report that is consistent the format and content of the development safety update report (DSUR) supported by the International Council of Harmonisiation.